Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bioadaptives (BDPT) Shares Outstanding (2019 - 2025)

Bioadaptives' Shares Outstanding history spans 7 years, with the latest figure at $12.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $12.0 million for Q4 2025, up 46.17% from a year ago — trailing twelve months through Dec 2025 was $12.0 million (up 46.17% YoY), and the annual figure for FY2025 was $12.0 million, up 46.17%.
  • Shares Outstanding for Q4 2025 was $12.0 million at Bioadaptives, up from $10.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $576.5 million in Q2 2023 to a low of $5333.0 in Q4 2022.
  • The 5-year median for Shares Outstanding is $8.2 million (2024), against an average of $38.1 million.
  • The sharpest move saw Shares Outstanding crashed 99.66% in 2024, then skyrocketed 113055.32% in 2025.
  • Year by year, Shares Outstanding stood at $50.8 million in 2021, then crashed by 96.69% to $1.7 million in 2022, then soared by 254.68% to $6.0 million in 2023, then surged by 37.57% to $8.2 million in 2024, then skyrocketed by 46.17% to $12.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $12.0 million, $10.9 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.